Global Pruritus Drugs Market By Product(Oral, Topical, Parenteral), By Application(Oncological Pruritus, Hematologic Pruritus, Renal Pruritus, Endocrine Pruritus, Cholestatic Pruritus), By Region And Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, And Forecast 2024-2033
-
45461
-
May 2024
-
300
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Quick Navigation
Report Overview
The Global Pruritus Drugs Market was valued at USD 8.2 billion in 2023. It is expected to reach USD 12.5 billion by 2033, with a CAGR of 4.4% during the forecast period from 2024 to 2033.
The Pruritus Drugs Market comprises pharmaceuticals designed to alleviate itching associated with various dermal conditions, including dermatitis, psoriasis, and allergic reactions. As pruritus can significantly impair quality of life, the demand for effective treatments is persistent across healthcare settings. This market segment addresses needs spanning topical agents, antihistamines, corticosteroids, and newer biologics that target underlying inflammatory processes.
Executives such as Product Managers should note the market's potential for expansion driven by increasing dermatological diagnoses and the development of innovative, patient-centric therapies. Strategic investment in this area promises growth and opportunities for differentiation in a competitive landscape.
The Pruritus Drugs Market is poised for substantial growth, fueled by a persistent demand for effective treatments across various pruritus-related conditions. An analysis reveals that pruritus, particularly when associated with primary biliary cholangitis, is often inadequately addressed, with approximately 33% of patients suffering from clinically significant pruritus not receiving the necessary treatment. This under-treatment highlights a significant gap in the current market offerings and presents a robust opportunity for pharmaceutical companies to introduce or improve pruritus-specific therapies.
Furthermore, the global burden of atopic dermatitis, a common cause of pruritus, continues to expand. In 2022, it was reported that around 223 million individuals worldwide were affected by this condition, including about 43 million children between the ages of 1 to 4 years. This demographic subset represents a particularly acute market segment that could benefit from pediatric-appropriate pruritus treatments, which are currently limited in both availability and efficacy.
Given these factors, the market for pruritus drugs is not only growing but also evolving with a marked shift towards developing treatments that can offer relief across a broader spectrum of symptoms and patient demographics. Companies venturing into this space can capitalize on the unmet medical needs by leveraging advanced R&D, strategic partnerships, and patient-centric treatment approaches. The potential for market expansion and profitability appears promising, contingent on the industry’s ability to innovate and address these critical gaps in care.
Key Takeaways
- Market Growth: The Global Pruritus Drugs Market was valued at USD 8.2 billion in 2023. It is expected to reach USD 12.5 billion by 2033, with a CAGR of 4.4% during the forecast period from 2024 to 2033.
- By Product: Oral formulations dominated the market with a 60% share.
- By Application: Oncological pruritus accounted for 32% of market dominance.
- Regional Dominance: North America holds a 46% share of the global pruritus drugs market.
- Growth Opportunity: The global pruritus drugs market is expanding with advancements in targeted therapies and increasing demand for topical and oral corticosteroids, driven by efficacy and evolving patient needs.
Driving factors
Increasing Prevalence of Skin Diseases
The increasing prevalence of skin diseases globally acts as a primary catalyst for the growth of the Pruritus Drugs Market. Dermatological conditions such as eczema, psoriasis, and atopic dermatitis, which often manifest with pruritus (itching), have been reported with rising incidence rates.
This trend significantly drives the demand for effective pruritus treatments. As the number of individuals suffering from these conditions grows, so does the patient pool requiring medical interventions for itch relief, thereby expanding the market size for pruritus drugs.
Streamlining of Regulatory Approvals and Licensing
The standardization and streamlining of regulatory approvals and licensing processes significantly enhance the pruritus drugs market's growth potential. By simplifying and expediting the regulatory framework, pharmaceutical companies can reduce the time and resources required to bring new pruritus treatments to market.
This efficiency not only speeds up product launches but also encourages companies to invest in the development of new and improved pruritus therapies, knowing that the pathway to market approval is becoming increasingly navigable.
Mergers, Acquisitions, and Partnerships
Mergers, acquisitions, and strategic partnerships within the pharmaceutical industry have proven to be decisive factors in the development and distribution of pruritus treatments. These collaborations often result in enhanced research and development capabilities, sharing of technological expertise, and expanded distribution networks, which collectively boost the market's growth.
By combining resources and expertise, companies can accelerate the development of innovative pruritus drugs and expand their reach to untapped markets, further driving market expansion.
Restraining Factors
Side Effects of Existing Medications
One significant restraint in the pruritus drugs market is the side effects associated with existing medications. Many current pruritus treatments come with a range of potential side effects, from mild discomforts like dry skin and dizziness to more severe reactions such as immune system suppression when using corticosteroids.
These adverse effects can deter patients from continuing or initiating therapy, directly impacting patient compliance and the overall demand for these drugs. The fear of side effects can also influence healthcare providers' prescribing behaviors, potentially restricting the market's expansion.
High Cost of Treatment
The high cost of pruritus treatments poses another substantial barrier to market growth. Advanced therapies, particularly those involving newer pharmaceutical formulations or biologics, can be prohibitively expensive, making them inaccessible to a significant portion of the potential patient base, especially in less developed regions.
This economic factor not only limits the market size directly by reducing the number of patients who can afford these treatments but also indirectly by influencing insurance coverage and reimbursement policies, which may not favor high-cost treatments unless they demonstrate clear cost-benefit advantages.
By Product Analysis
The oral segment dominated the market, accounting for 60% of total sales.
In 2023, the Pruritus Drugs Market was notably segmented into three primary delivery forms: Oral, Topical, and Parenteral. Oral medications held a dominant market position within this category, capturing more than 60% of the market share. This substantial share can be attributed to the preference for oral drugs due to their ease of administration and efficacy in managing systemic pruritic conditions.
Topical treatments, while less prevalent than oral formulations, also play a critical role in the management of pruritus, particularly for localized symptoms. These formulations are favored for their direct application, which minimizes systemic exposure and potential side effects. Despite their targeted approach, topical treatments accounted for a smaller segment of the market.
Parenteral routes, typically reserved for more severe or refractory cases of pruritus, constituted the smallest market segment. These formulations are usually administered in a clinical setting, limiting their use to cases where oral and topical treatments are ineffective.
The dominance of oral pruritus drugs is further reinforced by ongoing advancements in pharmaceutical formulations, which improve bioavailability and patient compliance, thus supporting market growth. Additionally, the development of newer agents that can effectively target underlying causes of pruritus via systemic routes continues to drive preference for oral medications.
By Application Analysis
Oncological pruritus led, representing 32% of the overall market share.
In 2023, the Pruritus Drugs Market was segmented by application into Oncological Pruritus, Hematologic Pruritus, Renal Pruritus, Endocrine Pruritus, and Cholestatic Pruritus. Oncological Pruritus held a dominant market position, capturing more than a 32% share. This prevalence is primarily due to the high incidence of pruritus as a common symptom in cancer patients, often resulting from either the malignancy itself or as a side effect of oncological treatments such as chemotherapy and radiation.
Hematologic Pruritus, associated with disorders such as polycythemia vera, also constituted a significant portion of the market. The need for specific treatments targeting the underlying hematologic causes of itch contributes to the segment’s robust presence in the market landscape.
Renal Pruritus, is prevalent in patients with chronic kidney disease or those on dialysis, and Endocrine Pruritus, often linked with thyroid dysfunctions, represents other critical segments. These conditions frequently necessitate long-term management strategies, underpinning steady demand within the pruritus therapeutics market.
Cholestatic Pruritus, which occurs in conditions affecting bile flow such as primary biliary cholangitis, though a smaller segment, is notably driven by the lack of effective treatments for the underlying liver conditions, thus highlighting an area of unmet medical need and opportunity for drug development.
The segmentation of the market by application underscores the diverse etiologies of pruritus and the necessity for specialized therapeutic approaches tailored to the pathophysiology of each condition, thereby driving the development and adoption of targeted pruritus drugs.
Key Market Segments
By Product
- Oral
- Topical
- Parenteral
By Application
- Oncological Pruritus
- Hematologic Pruritus
- Renal Pruritus
- Endocrine Pruritus
- Cholestatic Pruritus
Growth Opportunity
Opportunities in the Development of Novel Targeted Therapies for Pruritus
The global pruritus drugs market is poised for transformation as opportunities abound in the development of novel targeted therapies. These innovative treatments focus on addressing the underlying causes of pruritus with increased specificity and fewer side effects compared to traditional therapies. The shift towards targeted therapies can be attributed to advancements in understanding the pathophysiology of pruritus, which have unveiled new molecular targets.
This development not only promises enhanced efficacy but also reduces the burden of side effects, a crucial factor in patient compliance and satisfaction. The introduction of these novel drugs is expected to catalyze market growth, as they meet the unfulfilled needs of patients seeking more effective and safer treatment options.
Rising Demand for Topical and Oral Corticosteroids in Pruritus Treatment
Parallel to the innovation in targeted therapies, there is a rising demand for topical and oral corticosteroids, driven by their established efficacy in managing pruritus symptoms. These medications remain a cornerstone in pruritus treatment, particularly for conditions like atopic dermatitis and psoriasis, where inflammation plays a significant role.
The demand is further buoyed by the development of formulations that minimize systemic absorption and side effects. As the prevalence of allergic reactions and autoimmune diseases continues to rise globally, the demand for these corticosteroids is expected to surge, supporting the overall growth of the pruritus drugs market. This trend underscores the market's expansion as it adapts to the evolving healthcare needs and preferences of a growing patient population.
Latest Trends
Increased Interest in Non-Prescription Medications for Pruritus
In 2023, the global pruritus drugs market is witnessing a significant shift towards non-prescription medications. This trend is driven by a growing consumer preference for over-the-counter (OTC) options that allow for self-treatment of pruritus without the need for medical supervision. OTC medications are becoming increasingly popular due to their perceived safety, convenience, and cost-effectiveness.
Manufacturers are responding to this demand by expanding their portfolios of OTC pruritus treatments, which are formulated to meet stringent safety standards while providing effective symptom relief. This shift is not only democratizing pruritus treatment but also stimulating market growth as accessibility to these treatments broadens.
Role of Digital Therapeutics in Managing Pruritus
Concurrently, there is an emerging trend in the pruritus drugs market involving the integration of digital therapeutics. These innovative solutions, including mobile applications and wearable devices, are designed to manage pruritus through non-pharmacological means. Digital therapeutics offer personalized treatment options based on user input, leveraging technology to track symptoms, trigger factors, and treatment efficacy.
This approach supports self-management and can be used in conjunction with traditional medications, enhancing overall treatment outcomes. The adoption of digital therapeutics is expanding as patients and healthcare providers recognize their potential to provide real-time, data-driven insights into pruritus management, marking a forward-thinking development in the market landscape.
Regional Analysis
North America holds a 46% share of the global pruritus drugs market, leading in demand.
The global pruritus drugs market exhibits varied dynamics across different regions, reflecting distinct healthcare infrastructures, regulatory landscapes, and patient demographics. North America dominates the market, accounting for 46% of the global share. This substantial market presence is fueled by advanced healthcare systems, high awareness of treatment options, and the presence of major pharmaceutical companies engaged in pruritus drug development.
Europe follows as a significant player, driven by robust healthcare policies and a growing elderly population susceptible to skin conditions that cause pruritus. The region benefits from favorable reimbursement scenarios and strong initiatives promoting skin health, which bolster the demand for pruritus medications.
The Asia Pacific region is identified as the fastest-growing segment within the pruritus drugs market. This growth is propelled by increasing healthcare expenditure, rising awareness of dermatological conditions, and the expanding presence of international pharmaceutical companies. Countries like China and India are pivotal markets, due to their large populations and increasing access to healthcare services.
The Middle East & Africa, and Latin America regions, though smaller in market share, are emerging as potential growth areas. These regions are experiencing gradual growth due to improved healthcare infrastructure, rising disposable incomes, and an increasing prevalence of dermatological disorders. Public health initiatives and an expanding generic drugs market are supporting the growth in these regions.
Key Regions and Countries
North America
- The US
- Canada
- Rest of North America
Europe
- Germany
- France
- The UK
- Spain
- Netherlands
- Russia
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- Singapore
- Thailand
- South Korea
- Vietnam
- India
- New Zealand
- Rest of Asia Pacific
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East & Africa
Key Players Analysis
In 2023, the global pruritus drugs market will be shaped by strategic initiatives and diverse portfolios of key players. AbbVie Inc., renowned for its innovative approaches, continues to lead with targeted therapies that address underlying causes of pruritus. Similarly, Astellas Pharma Inc. and Eli Lilly and Co. are at the forefront due to their commitment to developing next-generation biologics with improved efficacy and safety profiles.
Almirall SA and Bristol-Myers Squibb Co. stand out for their robust pipelines in dermatological research, focusing on new molecular targets. Cara Therapeutics Inc., on the other hand, has gained attention with its novel kappa opioid receptor agonists that offer a unique mechanism of action to treat pruritus without the side effects associated with traditional treatments.
In the Asia-Pacific region, companies like Sun Pharmaceutical Industries Ltd. and Cipla Ltd. are expanding their market presence by leveraging cost-effective production and extensive distribution networks. These companies are vital in making pruritus medications more accessible in emerging markets.
Glenmark Pharmaceuticals Ltd., Lupin Ltd., and Ipca Laboratories Ltd. contribute significantly to the generic drugs segment, offering affordable alternatives to patented medications. This approach is crucial in regions where cost constraints are a major barrier to accessing healthcare.
Merck and Co. Inc., Novartis AG, and Pfizer Inc. continue to dominate through their extensive research and development capabilities. These companies are investing heavily in new drug formulations and delivery systems to enhance the patient experience.
Roivant Sciences Ltd., Sanofi SA, and GlaxoSmithKline Plc are exploring digital therapeutics and advanced drug delivery systems to complement their pharmaceutical offerings, thereby enhancing treatment efficacy and patient compliance.
Market Key Players
- AbbVie Inc.
- Almirall SA
- Astellas Pharma Inc.
- Bristol-Myers Squibb Co.
- Cara Therapeutics Inc.
- Eisai Co. Ltd.
- Eli Lilly and Co.
- Glenmark Pharmaceuticals Ltd.
- Ipca Laboratories Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Roivant Sciences Ltd.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Cipla Ltd.
- GlaxoSmithKline Plc
- Lupin Ltd.
Recent Development
- In April 2024, Livmarli was recommended for Canadian reimbursement by the CADTH committee, aiding Alagille syndrome patients with pruritus. Mirum Pharmaceuticals' CEO Chris Peetz lauds the decision, aiming for wider access across provinces.
- In March 2024, the FDA approved Mirum Pharmaceuticals' LIVMARLI for cholestatic pruritus in PFIC patients aged 5 and above. Phase III MARCH trial data support the breakthrough therapy, advancing treatment options.
Report Scope
Report Features Description Market Value (2023) USD 8.2 Billion Forecast Revenue (2033) USD 12.5 Billion CAGR (2024-2032) 4.4% Base Year for Estimation 2023 Historic Period 2016-2023 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered By Product(Oral, Topical, Parenteral), By Application(Oncological Pruritus, Hematologic Pruritus, Renal Pruritus, Endocrine Pruritus, Cholestatic Pruritus) Regional Analysis North America - The US, Canada, Rest of North America, Europe - Germany, France, The UK, Spain, Italy, Russia, Netherlands, Rest of Europe, Asia-Pacific - China, Japan, South Korea, India, New Zealand, Singapore, Thailand, Vietnam, Rest of Asia Pacific, Latin America - Brazil, Mexico, Rest of Latin America, Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa Competitive Landscape AbbVie Inc., Almirall SA, Astellas Pharma Inc., Bristol-Myers Squibb Co., Cara Therapeutics Inc., Eisai Co. Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Roivant Sciences Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Cipla Ltd., GlaxoSmithKline Plc, Lupin Ltd. Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) -
- 1. Executive Summary
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 1.4. Key Analysis
- 1.5. Key Findings by Major Segments
- 1.6. Top strategies by Major Players
- 2. Global Pruritus Drugs Market Overview
- 2.1. Pruritus Drugs Market Dynamics
- 2.1.1. Drivers
- 2.1.2. Opportunities
- 2.1.3. Restraints
- 2.1.4. Challenges
- 2.2. Macro-economic Factors
- 2.3. Regulatory Framework
- 2.4. Market Investment Feasibility Index
- 2.5. PEST Analysis
- 2.6. PORTER’S Five Force Analysis
- 2.7. Drivers & Restraints Impact Analysis
- 2.8. Industry Chain Analysis
- 2.9. Cost Structure Analysis
- 2.10. Marketing Strategy
- 2.11. Russia-Ukraine War Impact Analysis
- 2.12. Opportunity Map Analysis
- 2.13. Market Competition Scenario Analysis
- 2.14. Product Life Cycle Analysis
- 2.15. Opportunity Orbits
- 2.16. Manufacturer Intensity Map
- 2.17. Major Companies sales by Value & Volume
- 2.1. Pruritus Drugs Market Dynamics
- 3. Global Pruritus Drugs Market Analysis, Opportunity and Forecast, 2016-2032
- 3.1. Global Pruritus Drugs Market Analysis, 2016-2021
- 3.2. Global Pruritus Drugs Market Opportunity and Forecast, 2023-2032
- 3.3. Global Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Product, 2016-2032
- 3.3.1. Global Pruritus Drugs Market Analysis by By Product: Introduction
- 3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product, 2016-2032
- 3.3.3. Oral
- 3.3.4. Topical
- 3.3.5. Parenteral
- 3.4. Global Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 3.4.1. Global Pruritus Drugs Market Analysis by By Application: Introduction
- 3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 3.4.3. Oncological Pruritus
- 3.4.4. Hematologic Pruritus
- 3.4.5. Renal Pruritus
- 3.4.6. Endocrine Pruritus
- 3.4.7. Cholestatic Pruritus
- 4. North America Pruritus Drugs Market Analysis, Opportunity and Forecast, 2016-2032
- 4.1. North America Pruritus Drugs Market Analysis, 2016-2021
- 4.2. North America Pruritus Drugs Market Opportunity and Forecast, 2023-2032
- 4.3. North America Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Product, 2016-2032
- 4.3.1. North America Pruritus Drugs Market Analysis by By Product: Introduction
- 4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product, 2016-2032
- 4.3.3. Oral
- 4.3.4. Topical
- 4.3.5. Parenteral
- 4.4. North America Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 4.4.1. North America Pruritus Drugs Market Analysis by By Application: Introduction
- 4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 4.4.3. Oncological Pruritus
- 4.4.4. Hematologic Pruritus
- 4.4.5. Renal Pruritus
- 4.4.6. Endocrine Pruritus
- 4.4.7. Cholestatic Pruritus
- 4.5. North America Pruritus Drugs Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 4.5.1. North America Pruritus Drugs Market Analysis by Country : Introduction
- 4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 4.5.2.1. The US
- 4.5.2.2. Canada
- 4.5.2.3. Mexico
- 5. Western Europe Pruritus Drugs Market Analysis, Opportunity and Forecast, 2016-2032
- 5.1. Western Europe Pruritus Drugs Market Analysis, 2016-2021
- 5.2. Western Europe Pruritus Drugs Market Opportunity and Forecast, 2023-2032
- 5.3. Western Europe Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Product, 2016-2032
- 5.3.1. Western Europe Pruritus Drugs Market Analysis by By Product: Introduction
- 5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product, 2016-2032
- 5.3.3. Oral
- 5.3.4. Topical
- 5.3.5. Parenteral
- 5.4. Western Europe Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 5.4.1. Western Europe Pruritus Drugs Market Analysis by By Application: Introduction
- 5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 5.4.3. Oncological Pruritus
- 5.4.4. Hematologic Pruritus
- 5.4.5. Renal Pruritus
- 5.4.6. Endocrine Pruritus
- 5.4.7. Cholestatic Pruritus
- 5.5. Western Europe Pruritus Drugs Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 5.5.1. Western Europe Pruritus Drugs Market Analysis by Country : Introduction
- 5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 5.5.2.1. Germany
- 5.5.2.2. France
- 5.5.2.3. The UK
- 5.5.2.4. Spain
- 5.5.2.5. Italy
- 5.5.2.6. Portugal
- 5.5.2.7. Ireland
- 5.5.2.8. Austria
- 5.5.2.9. Switzerland
- 5.5.2.10. Benelux
- 5.5.2.11. Nordic
- 5.5.2.12. Rest of Western Europe
- 6. Eastern Europe Pruritus Drugs Market Analysis, Opportunity and Forecast, 2016-2032
- 6.1. Eastern Europe Pruritus Drugs Market Analysis, 2016-2021
- 6.2. Eastern Europe Pruritus Drugs Market Opportunity and Forecast, 2023-2032
- 6.3. Eastern Europe Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Product, 2016-2032
- 6.3.1. Eastern Europe Pruritus Drugs Market Analysis by By Product: Introduction
- 6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product, 2016-2032
- 6.3.3. Oral
- 6.3.4. Topical
- 6.3.5. Parenteral
- 6.4. Eastern Europe Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 6.4.1. Eastern Europe Pruritus Drugs Market Analysis by By Application: Introduction
- 6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 6.4.3. Oncological Pruritus
- 6.4.4. Hematologic Pruritus
- 6.4.5. Renal Pruritus
- 6.4.6. Endocrine Pruritus
- 6.4.7. Cholestatic Pruritus
- 6.5. Eastern Europe Pruritus Drugs Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 6.5.1. Eastern Europe Pruritus Drugs Market Analysis by Country : Introduction
- 6.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 6.5.2.1. Russia
- 6.5.2.2. Poland
- 6.5.2.3. The Czech Republic
- 6.5.2.4. Greece
- 6.5.2.5. Rest of Eastern Europe
- 7. APAC Pruritus Drugs Market Analysis, Opportunity and Forecast, 2016-2032
- 7.1. APAC Pruritus Drugs Market Analysis, 2016-2021
- 7.2. APAC Pruritus Drugs Market Opportunity and Forecast, 2023-2032
- 7.3. APAC Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Product, 2016-2032
- 7.3.1. APAC Pruritus Drugs Market Analysis by By Product: Introduction
- 7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product, 2016-2032
- 7.3.3. Oral
- 7.3.4. Topical
- 7.3.5. Parenteral
- 7.4. APAC Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 7.4.1. APAC Pruritus Drugs Market Analysis by By Application: Introduction
- 7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 7.4.3. Oncological Pruritus
- 7.4.4. Hematologic Pruritus
- 7.4.5. Renal Pruritus
- 7.4.6. Endocrine Pruritus
- 7.4.7. Cholestatic Pruritus
- 7.5. APAC Pruritus Drugs Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 7.5.1. APAC Pruritus Drugs Market Analysis by Country : Introduction
- 7.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 7.5.2.1. China
- 7.5.2.2. Japan
- 7.5.2.3. South Korea
- 7.5.2.4. India
- 7.5.2.5. Australia & New Zeland
- 7.5.2.6. Indonesia
- 7.5.2.7. Malaysia
- 7.5.2.8. Philippines
- 7.5.2.9. Singapore
- 7.5.2.10. Thailand
- 7.5.2.11. Vietnam
- 7.5.2.12. Rest of APAC
- 8. Latin America Pruritus Drugs Market Analysis, Opportunity and Forecast, 2016-2032
- 8.1. Latin America Pruritus Drugs Market Analysis, 2016-2021
- 8.2. Latin America Pruritus Drugs Market Opportunity and Forecast, 2023-2032
- 8.3. Latin America Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Product, 2016-2032
- 8.3.1. Latin America Pruritus Drugs Market Analysis by By Product: Introduction
- 8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product, 2016-2032
- 8.3.3. Oral
- 8.3.4. Topical
- 8.3.5. Parenteral
- 8.4. Latin America Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 8.4.1. Latin America Pruritus Drugs Market Analysis by By Application: Introduction
- 8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 8.4.3. Oncological Pruritus
- 8.4.4. Hematologic Pruritus
- 8.4.5. Renal Pruritus
- 8.4.6. Endocrine Pruritus
- 8.4.7. Cholestatic Pruritus
- 8.5. Latin America Pruritus Drugs Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 8.5.1. Latin America Pruritus Drugs Market Analysis by Country : Introduction
- 8.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 8.5.2.1. Brazil
- 8.5.2.2. Colombia
- 8.5.2.3. Chile
- 8.5.2.4. Argentina
- 8.5.2.5. Costa Rica
- 8.5.2.6. Rest of Latin America
- 9. Middle East & Africa Pruritus Drugs Market Analysis, Opportunity and Forecast, 2016-2032
- 9.1. Middle East & Africa Pruritus Drugs Market Analysis, 2016-2021
- 9.2. Middle East & Africa Pruritus Drugs Market Opportunity and Forecast, 2023-2032
- 9.3. Middle East & Africa Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Product, 2016-2032
- 9.3.1. Middle East & Africa Pruritus Drugs Market Analysis by By Product: Introduction
- 9.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Product, 2016-2032
- 9.3.3. Oral
- 9.3.4. Topical
- 9.3.5. Parenteral
- 9.4. Middle East & Africa Pruritus Drugs Market Analysis, Opportunity and Forecast, By By Application, 2016-2032
- 9.4.1. Middle East & Africa Pruritus Drugs Market Analysis by By Application: Introduction
- 9.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By By Application, 2016-2032
- 9.4.3. Oncological Pruritus
- 9.4.4. Hematologic Pruritus
- 9.4.5. Renal Pruritus
- 9.4.6. Endocrine Pruritus
- 9.4.7. Cholestatic Pruritus
- 9.5. Middle East & Africa Pruritus Drugs Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 9.5.1. Middle East & Africa Pruritus Drugs Market Analysis by Country : Introduction
- 9.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 9.5.2.1. Algeria
- 9.5.2.2. Egypt
- 9.5.2.3. Israel
- 9.5.2.4. Kuwait
- 9.5.2.5. Nigeria
- 9.5.2.6. Saudi Arabia
- 9.5.2.7. South Africa
- 9.5.2.8. Turkey
- 9.5.2.9. The UAE
- 9.5.2.10. Rest of MEA
- 10. Global Pruritus Drugs Market Analysis, Opportunity and Forecast, By Region , 2016-2032
- 10.1. Global Pruritus Drugs Market Analysis by Region : Introduction
- 10.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
- 10.2.1. North America
- 10.2.2. Western Europe
- 10.2.3. Eastern Europe
- 10.2.4. APAC
- 10.2.5. Latin America
- 10.2.6. Middle East & Africa
- 11. Global Pruritus Drugs Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 11.1. Market Share Analysis
- 11.2. Company Profiles
- 11.3. AbbVie Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Highlights
- 11.3.3. Product Portfolio
- 11.3.4. SWOT Analysis
- 11.3.5. Key Strategies and Developments
- 11.4. Almirall SA
- 11.4.1. Company Overview
- 11.4.2. Financial Highlights
- 11.4.3. Product Portfolio
- 11.4.4. SWOT Analysis
- 11.4.5. Key Strategies and Developments
- 11.5. Astellas Pharma Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Highlights
- 11.5.3. Product Portfolio
- 11.5.4. SWOT Analysis
- 11.5.5. Key Strategies and Developments
- 11.6. Bristol-Myers Squibb Co.
- 11.6.1. Company Overview
- 11.6.2. Financial Highlights
- 11.6.3. Product Portfolio
- 11.6.4. SWOT Analysis
- 11.6.5. Key Strategies and Developments
- 11.7. Cara Therapeutics Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Highlights
- 11.7.3. Product Portfolio
- 11.7.4. SWOT Analysis
- 11.7.5. Key Strategies and Developments
- 11.8. Eisai Co. Ltd.
- 11.8.1. Company Overview
- 11.8.2. Financial Highlights
- 11.8.3. Product Portfolio
- 11.8.4. SWOT Analysis
- 11.8.5. Key Strategies and Developments
- 11.9. Eli Lilly and Co.
- 11.9.1. Company Overview
- 11.9.2. Financial Highlights
- 11.9.3. Product Portfolio
- 11.9.4. SWOT Analysis
- 11.9.5. Key Strategies and Developments
- 11.10. Glenmark Pharmaceuticals Ltd.
- 11.10.1. Company Overview
- 11.10.2. Financial Highlights
- 11.10.3. Product Portfolio
- 11.10.4. SWOT Analysis
- 11.10.5. Key Strategies and Developments
- 11.11. Ipca Laboratories Ltd.
- 11.11.1. Company Overview
- 11.11.2. Financial Highlights
- 11.11.3. Product Portfolio
- 11.11.4. SWOT Analysis
- 11.11.5. Key Strategies and Developments
- 11.12. Merck and Co. Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Highlights
- 11.12.3. Product Portfolio
- 11.12.4. SWOT Analysis
- 11.12.5. Key Strategies and Developments
- 11.13.1. Company Overview
- 11.13.2. Financial Highlights
- 11.13.3. Product Portfolio
- 11.13.4. SWOT Analysis
- 11.13.5. Key Strategies and Developments
- 11.14. Novartis AG
- 11.14.1. Company Overview
- 11.14.2. Financial Highlights
- 11.14.3. Product Portfolio
- 11.14.4. SWOT Analysis
- 11.14.5. Key Strategies and Developments
- 11.15. Roivant Sciences Ltd.
- 11.15.1. Company Overview
- 11.15.2. Financial Highlights
- 11.15.3. Product Portfolio
- 11.15.4. SWOT Analysis
- 11.15.5. Key Strategies and Developments
- 11.16. Sanofi SA
- 11.16.1. Company Overview
- 11.16.2. Financial Highlights
- 11.16.3. Product Portfolio
- 11.16.4. SWOT Analysis
- 11.16.5. Key Strategies and Developments
- 11.17. Sun Pharmaceutical Industries Ltd.
- 11.17.1. Company Overview
- 11.17.2. Financial Highlights
- 11.17.3. Product Portfolio
- 11.17.4. SWOT Analysis
- 11.17.5. Key Strategies and Developments
- 11.18. Cipla Ltd.
- 11.18.1. Company Overview
- 11.18.2. Financial Highlights
- 11.18.3. Product Portfolio
- 11.18.4. SWOT Analysis
- 11.18.5. Key Strategies and Developments
- 11.19. GlaxoSmithKline Plc
- 11.19.1. Company Overview
- 11.19.2. Financial Highlights
- 11.19.3. Product Portfolio
- 11.19.4. SWOT Analysis
- 11.19.5. Key Strategies and Developments
- 11.20. Lupin Ltd.
- 11.20.1. Company Overview
- 11.20.2. Financial Highlights
- 11.20.3. Product Portfolio
- 11.20.4. SWOT Analysis
- 11.20.5. Key Strategies and Developments
- 12. Assumptions and Acronyms
- 13. Research Methodology
- 14. Contact
"
- List of Figures
- "
- Figure 1: Global Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Product in 2022
- Figure 2: Global Pruritus Drugs Market Market Attractiveness Analysis by By Product, 2016-2032
- Figure 3: Global Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 4: Global Pruritus Drugs Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 5: Global Pruritus Drugs Market Revenue (US$ Mn) Market Share by Region in 2022
- Figure 6: Global Pruritus Drugs Market Market Attractiveness Analysis by Region, 2016-2032
- Figure 7: Global Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Figure 8: Global Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Figure 9: Global Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 10: Global Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 11: Global Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Figure 12: Global Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 13: Global Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 14: Global Pruritus Drugs Market Market Share Comparison by Region (2016-2032)
- Figure 15: Global Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Figure 16: Global Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Figure 17: North America Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Productin 2022
- Figure 18: North America Pruritus Drugs Market Market Attractiveness Analysis by By Product, 2016-2032
- Figure 19: North America Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 20: North America Pruritus Drugs Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 21: North America Pruritus Drugs Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 22: North America Pruritus Drugs Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 23: North America Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Figure 24: North America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 25: North America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 26: North America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 27: North America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 28: North America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 29: North America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 30: North America Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Figure 31: North America Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Figure 32: North America Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Figure 33: Western Europe Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Productin 2022
- Figure 34: Western Europe Pruritus Drugs Market Market Attractiveness Analysis by By Product, 2016-2032
- Figure 35: Western Europe Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 36: Western Europe Pruritus Drugs Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 37: Western Europe Pruritus Drugs Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 38: Western Europe Pruritus Drugs Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 39: Western Europe Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Figure 40: Western Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 41: Western Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 42: Western Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 43: Western Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 44: Western Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 45: Western Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 46: Western Europe Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Figure 47: Western Europe Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Figure 48: Western Europe Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Figure 49: Eastern Europe Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Productin 2022
- Figure 50: Eastern Europe Pruritus Drugs Market Market Attractiveness Analysis by By Product, 2016-2032
- Figure 51: Eastern Europe Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 52: Eastern Europe Pruritus Drugs Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 53: Eastern Europe Pruritus Drugs Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 54: Eastern Europe Pruritus Drugs Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 55: Eastern Europe Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Figure 56: Eastern Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 57: Eastern Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 58: Eastern Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 59: Eastern Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 60: Eastern Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 61: Eastern Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 62: Eastern Europe Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Figure 63: Eastern Europe Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Figure 64: Eastern Europe Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Figure 65: APAC Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Productin 2022
- Figure 66: APAC Pruritus Drugs Market Market Attractiveness Analysis by By Product, 2016-2032
- Figure 67: APAC Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 68: APAC Pruritus Drugs Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 69: APAC Pruritus Drugs Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 70: APAC Pruritus Drugs Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 71: APAC Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Figure 72: APAC Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 73: APAC Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 74: APAC Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 75: APAC Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 76: APAC Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 77: APAC Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 78: APAC Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Figure 79: APAC Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Figure 80: APAC Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Figure 81: Latin America Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Productin 2022
- Figure 82: Latin America Pruritus Drugs Market Market Attractiveness Analysis by By Product, 2016-2032
- Figure 83: Latin America Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 84: Latin America Pruritus Drugs Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 85: Latin America Pruritus Drugs Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 86: Latin America Pruritus Drugs Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 87: Latin America Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Figure 88: Latin America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 89: Latin America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 90: Latin America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 91: Latin America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 92: Latin America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 93: Latin America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 94: Latin America Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Figure 95: Latin America Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Figure 96: Latin America Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Figure 97: Middle East & Africa Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Productin 2022
- Figure 98: Middle East & Africa Pruritus Drugs Market Market Attractiveness Analysis by By Product, 2016-2032
- Figure 99: Middle East & Africa Pruritus Drugs Market Revenue (US$ Mn) Market Share by By Applicationin 2022
- Figure 100: Middle East & Africa Pruritus Drugs Market Market Attractiveness Analysis by By Application, 2016-2032
- Figure 101: Middle East & Africa Pruritus Drugs Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 102: Middle East & Africa Pruritus Drugs Market Market Attractiveness Analysis by Country, 2016-2032
- Figure 103: Middle East & Africa Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Figure 104: Middle East & Africa Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 105: Middle East & Africa Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Figure 106: Middle East & Africa Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Figure 107: Middle East & Africa Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 108: Middle East & Africa Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Figure 109: Middle East & Africa Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Figure 110: Middle East & Africa Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Figure 111: Middle East & Africa Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Figure 112: Middle East & Africa Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
"
- List of Tables
- "
- Table 1: Global Pruritus Drugs Market Market Comparison by By Product (2016-2032)
- Table 2: Global Pruritus Drugs Market Market Comparison by By Application (2016-2032)
- Table 3: Global Pruritus Drugs Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 4: Global Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Table 5: Global Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 6: Global Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 7: Global Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 8: Global Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Table 9: Global Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 10: Global Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 11: Global Pruritus Drugs Market Market Share Comparison by Region (2016-2032)
- Table 12: Global Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Table 13: Global Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Table 14: North America Pruritus Drugs Market Market Comparison by By Application (2016-2032)
- Table 15: North America Pruritus Drugs Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 16: North America Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Table 17: North America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 18: North America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 19: North America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 20: North America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 21: North America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 22: North America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 23: North America Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Table 24: North America Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Table 25: North America Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Table 26: Western Europe Pruritus Drugs Market Market Comparison by By Product (2016-2032)
- Table 27: Western Europe Pruritus Drugs Market Market Comparison by By Application (2016-2032)
- Table 28: Western Europe Pruritus Drugs Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 29: Western Europe Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Table 30: Western Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 31: Western Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 32: Western Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 33: Western Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 34: Western Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 35: Western Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 36: Western Europe Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Table 37: Western Europe Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Table 38: Western Europe Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Table 39: Eastern Europe Pruritus Drugs Market Market Comparison by By Product (2016-2032)
- Table 40: Eastern Europe Pruritus Drugs Market Market Comparison by By Application (2016-2032)
- Table 41: Eastern Europe Pruritus Drugs Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 42: Eastern Europe Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Table 43: Eastern Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 44: Eastern Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 45: Eastern Europe Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 46: Eastern Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 47: Eastern Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 48: Eastern Europe Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 49: Eastern Europe Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Table 50: Eastern Europe Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Table 51: Eastern Europe Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Table 52: APAC Pruritus Drugs Market Market Comparison by By Product (2016-2032)
- Table 53: APAC Pruritus Drugs Market Market Comparison by By Application (2016-2032)
- Table 54: APAC Pruritus Drugs Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 55: APAC Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Table 56: APAC Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 57: APAC Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 58: APAC Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 59: APAC Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 60: APAC Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 61: APAC Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 62: APAC Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Table 63: APAC Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Table 64: APAC Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Table 65: Latin America Pruritus Drugs Market Market Comparison by By Product (2016-2032)
- Table 66: Latin America Pruritus Drugs Market Market Comparison by By Application (2016-2032)
- Table 67: Latin America Pruritus Drugs Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 68: Latin America Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Table 69: Latin America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 70: Latin America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 71: Latin America Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 72: Latin America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 73: Latin America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 74: Latin America Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 75: Latin America Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Table 76: Latin America Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Table 77: Latin America Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- Table 78: Middle East & Africa Pruritus Drugs Market Market Comparison by By Product (2016-2032)
- Table 79: Middle East & Africa Pruritus Drugs Market Market Comparison by By Application (2016-2032)
- Table 80: Middle East & Africa Pruritus Drugs Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 81: Middle East & Africa Pruritus Drugs Market Market Revenue (US$ Mn) (2016-2032)
- Table 82: Middle East & Africa Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 83: Middle East & Africa Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Product (2016-2032)
- Table 84: Middle East & Africa Pruritus Drugs Market Market Revenue (US$ Mn) Comparison by By Application (2016-2032)
- Table 85: Middle East & Africa Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 86: Middle East & Africa Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Product (2016-2032)
- Table 87: Middle East & Africa Pruritus Drugs Market Market Y-o-Y Growth Rate Comparison by By Application (2016-2032)
- Table 88: Middle East & Africa Pruritus Drugs Market Market Share Comparison by Country (2016-2032)
- Table 89: Middle East & Africa Pruritus Drugs Market Market Share Comparison by By Product (2016-2032)
- Table 90: Middle East & Africa Pruritus Drugs Market Market Share Comparison by By Application (2016-2032)
- 1. Executive Summary
-
- AbbVie Inc.
- Almirall SA
- Astellas Pharma Inc.
- Bristol-Myers Squibb Co.
- Cara Therapeutics Inc.
- Eisai Co. Ltd.
- Eli Lilly and Co.
- Glenmark Pharmaceuticals Ltd.
- Ipca Laboratories Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Roivant Sciences Ltd.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Cipla Ltd.
- GlaxoSmithKline Plc
- Lupin Ltd.
Our Clients
View Our Licence Options
